. 
FOR MEDIA INFORMATION, CONTACT:
Yolanda Fintschenko, PhD
Executive Director, i-GATE Innovation Hub and Startup Tri-Valley
(925) 784-3597
FOR IMMEDIATE RELEASE
Tri-Valley Life Sciences Summit Highlights What It Takes to Turn Breakthrough Science Into Scalable Companies
200 industry leaders gathered to explore how customer focus, talent, infrastructure, and a supportive regional ecosystem can help life sciences companies grow
2026 Tri-Valley Life Sciences Summit
Presented by California Life Sciences, Kilpatrick, and FluidCloud
Organized by Startup Tri-Valley and the City of Pleasanton
PLEASANTON, CA, October 22, 2026 – Two hundred founders, scientists, executives, investors, educators, public officials, students, and ecosystem partners gathered for the 2026 Tri-Valley Life Sciences Summit, The Business of Breakthroughs: Life Sciences at Scale, presented by California Life Sciences, Kilpatrick, and FluidCloud and organized by Startup Tri-Valley and the City of Pleasanton.
The Summit focused on what it takes to move promising science into companies, products, and solutions that can grow and deliver real-world impact, while highlighting the Tri-Valley as a region where life sciences companies can find the talent, connections, support, and room they need to scale.
|
“The PitchBook data shows there is tremendous activity and opportunity in Northern California, but capital is only one part of the scaling story,” said Yolanda Fintschenko, Executive Director of i-GATE Innovation Hub, the nonprofit behind Startup Tri-Valley and Daybreak Labs. “Great science is only the beginning. Companies also need talented people, customers and partners, support, room to grow, and communities that want them to succeed. Across the Tri-Valley, we’re working to create those conditions and the connections that help breakthrough companies scale.” |
New PitchBook Data Shows Northern California Momentum
Data prepared by PitchBook for the Summit underscored the strength of the broader Northern California life sciences ecosystem, which PitchBook defines for this analysis as the Bay Area and the Tri-Valley.
In life sciences tools, deal value grew 225% in Northern California on a trailing-12-month basis compared with the prior trailing 12 months, versus 24% nationally. In medtech, Northern California deal value grew 90% from 2023 to 2025, compared with 34% across the United States.
The data also showed where investment is concentrating. In silico discovery, including companies using AI in drug discovery and development, accounted for 45% of life sciences tools deal value during the trailing 12 months, up from 10% in 2021. Surgical devices and tools accounted for 49% of medtech deal value, up from 31% in 2021.
At the same time, the data illustrates the challenge of scaling. For global life sciences tools exits, the median disclosed exit size declined from $216 million in 2021-2023 to $85 million in 2024-2026 YTD, while acquisitions and buyouts increased from 62% to 83% of exits. For medtech, the median time from first venture financing to exit increased from 7.2 years to 8.4 years between those periods.
That combination of strong regional investment activity and a demanding path to scale helped frame the Summit’s discussion about what companies need beyond capital: customers, talent, partnerships, operational discipline, infrastructure, and an ecosystem that supports growth.
View the special Northern California analysis prepared for the Summit: PitchBook Life Science Tools & Medtech Fact Sheet
Insights From Leaders Scaling Life Sciences Companies
A centerpiece of the Summit was a panel examining the realities of scaling life sciences companies, moderated by Julia Schaletzky, Executive Director of the Molecular Therapeutics Initiative at UC Berkeley. Schaletzky brought humor and momentum to a wide-ranging conversation with leaders representing different perspectives on growth and commercialization.
Anuj Kalra, President/Head of Business Chronic Disease Management ZEISS Medical Technology discussed sustaining innovation inside an established industry leader, including the importance of customer voice and product-market fit.
Yunfen (Fiona) He, President of OPM Biosciences, emphasized the importance of reproducible results and serving life sciences customers as a development partner rather than simply a vendor.
Jay Harger, Chief Operating Officer of Themis Bios, discussed the signals that indicate when a growing company needs greater process and operating discipline.
Schaletzky drew a common thread among the panelists, observing that more companies should listen to their customers the way these panelists do.
Why the Tri-Valley?
The discussion underscored a central theme of the Summit: successful commercialization requires an ecosystem around the science. For the Tri-Valley, that means connecting entrepreneurs with experienced talent, customers, partners, and resources while ensuring companies can find room to grow and communities that actively support their expansion.
Pleasanton Mayor Jack Balch welcomed attendees and highlighted specific policy changes the City of Pleasanton has made to support scaling life sciences companies.
| “Pleasanton is a hub for life sciences, particularly in diagnostics, med tech, and emerging contract research and development organizations. This Summit highlights the ecosystem we are building to scale companies in the Tri-Valley’s innovation economy and reinforces our commitment to building a more innovative future by bringing leaders together to spark new ideas and partnerships,” said Pleasanton Mayor Jack Balch. |
Presenting Sponsors Contribute to the Conversation
The Summit’s presenting sponsors also contributed directly to the program. Sepee Moin, Director of Business Development at California Life Sciences; Siegmar Pohl, Partner-in-Charge, and Yifan Mao, Partner and Patent Attorney, of Kilpatrick; and Sharad Kumar, Co-Founder and CEO of FluidCloud, addressed Summit attendees.
The 2026 Tri-Valley Life Sciences Summit was presented by California Life Sciences, Kilpatrick, and FluidCloud and organized by Startup Tri-Valley and the City of Pleasanton.
About Our Presenting Sponsors and Organizers
Presenting Sponsors
About California Life Sciences
California Life Sciences is the state’s life sciences membership organization, supporting companies ranging from early-stage innovators and startups to established biotechnology, pharmaceutical, and medical technology leaders. The organization works with universities, research institutions, investors, and other partners to advocate for and strengthen California’s life sciences sector. Learn more at califesciences.org
About Kilpatrick
Kilpatrick is a global law firm serving innovative companies through practical, business-focused legal counsel. Its Emerging Companies and Venture Capital practice works with startups, investors, and established businesses navigating company formation, financing, intellectual property, growth, and strategic transactions. Learn more at ktslaw.com
About FluidCloud
FluidCloud is redefining what is possible in multi-cloud infrastructure by helping organizations move beyond cloud provider lock-in. Its Cloud Cloning platform enables teams to clone, migrate, restore, and optimize infrastructure across clouds in minutes, giving organizations greater portability and flexibility in where they run workloads. FluidCloud is headquartered in Pleasanton, California. Learn more at fluidcloud.com
Event Organizers
About Startup Tri-Valley
Startup Tri-Valley is an initiative to grow and strengthen the region by helping more startups succeed. It connects founders and innovators to a network of resources built specifically for science-based startups. The initiative is supported by the Tri-Valley cities of Dublin, Livermore, and Pleasanton; the Town of Danville; Alameda County; and i-GATE Innovation Hub partners Lawrence Livermore and Sandia National Laboratories. Learn more at startuptrivalley.org
About i-GATE Innovation Hub
i-GATE Innovation Hub is a nonprofit organization focused on increasing economic prosperity through entrepreneurship in the Tri-Valley. Through Daybreak Labs and Startup Tri-Valley, i-GATE provides incubation resources, supports founders, and connects the regional innovation community. Learn more at igateihub.org
About the City of Pleasanton
Pleasanton is a vibrant Northern California community of close to 80,000 residents in the Tri-Valley region. Businesses benefit from a highly educated and skilled workforce and excellent connectivity throughout the Bay Area and beyond. The city is also known for its top-rated schools, a regional shopping mall, a charming historic downtown, abundant recreational opportunities, and a rich arts and cultural scene.
Pleasanton is a major innovation hub with a strong life sciences presence, including companies such as 10X Genomics, Roche Molecular, and Thermo Fisher. The city is also home to firms in the software, robotics, health care, electronics, and advanced manufacturing sectors. Learn more at: https://www.cityofpleasantonca.gov/our-government/economic-development/why-pleasanton/
###

IMAGE CAPTION: Yolanda Fintschenko, executive director, i-GATE, with panelists Fiona He, President and Co-Founder, OPM Bioscience, Anuj Kalra, President and Head of Chronic Disease, ZEISS Medical Technology, Mayor Jack Balch, City of Pleasanton, and panelist Jay Harger, COO, Themis Bios.
IMAGE CAPTION: Event organizers, sponsors, and speakers. Left to right, Brian Wilson, Colliers and Daybreak Labs Advisor, Panelist Jay Harger, COO, Themis Bios, Fiona He, co-founder and President, OPM Bioscience, Anuj Kalra, President and Head of Chronic Disease, ZEISS Medical Technology, Siegmar Pohl, Partner, Kilpatrick, Julia Schaletzky, UC Berkeley, Moderator, Yolanda Fintchenko, executive director, i-GATE Innovation Hub, Sepee Moin, Director of Business Development, California Life Sciences.
IMAGE CAPTION: Attendees at the 2026 Tri-Valley Life Sciences Summit connecting and enjoying the networking reception.

IMAGE CAPTION: Panel Discussion – left to right, Julia Schaletzky, UC Berkeley, moderator, Anuj Kalra, President, Head of Chronic Disease, ZEISS Medical Technology, Fiona He, President and co-founder, OPM Bioscience, and Jay Harger, COO, Themis Bios.
